Clinical Trial: Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: An Observational, Multicenter Study of the Prevalence of Cerebrotendinous Xanthomatosis (CTX) in Patient Populations Diagnosed With Early-Onset Idiopathic Bilateral Catara
Brief Summary: This is an observational, multicenter study to determine the prevalence of Cerebrotendinous Xanthomatosis (CTX) in patient populations diagnosed with early-onset idiopathic bilateral cataracts. Patients who are potentially eligible for study participation will be identified through a chart review of patients who were seen at each study site prior to that site's initiation, or by entering care at the site while the site is participating in the trial.
Detailed Summary:
Sponsor: Retrophin, Inc.
Current Primary Outcome: To calculate the prevalence of Cerebrotendinous Xanthomatosis (CTX) in a patient population diagnosed up to age 21 with early-onset idiopathic bilateral cataracts [ Time Frame: 8 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome: To assess other manifestations of CTX within patients presenting with idiopathic bilateral cataracts. [ Time Frame: 8 weeks ]
Original Secondary Outcome: Same as current
Information By: Retrophin, Inc.
Dates:
Date Received: November 23, 2015
Date Started: September 2015
Date Completion: December 2017
Last Updated: January 31, 2017
Last Verified: January 2017